About Congress
The 1st International Congress of Vaccine and Vaccination
A scientific, industrial, and strategic gathering connecting vaccine science, emerging technologies, biomanufacturing, health policy, and public trust to help shape an integrated and resilient vaccine ecosystem.
|
Core Approach
One Health
Human, Animal, and Environmental Health
|
Congress Scope
From Research to Vaccination
An Integrated Vaccine Value Chain
|
Future Vision
Innovation and Resilience
Preparedness for Future Health Challenges
|
The 1st International Congress of Vaccine and Vaccination is organized to establish a scientific, industrial, and strategic platform for developing and strengthening the vaccine ecosystem in Iran and the wider region. The congress provides an environment for knowledge exchange, interdisciplinary collaboration, and discussion of the opportunities and challenges shaping the future of vaccines.
With One Health at the center of its scientific and policy discussions, ICVV highlights the close relationship between human, animal, and environmental health. This integrated approach can support earlier identification of biological threats, stronger preparedness for emerging diseases, and more coordinated responses at national and regional levels.
Artificial intelligence, systems vaccinology, data-driven technologies, and advanced vaccine platforms are also among the principal areas of focus. The congress seeks to strengthen a connected pathway encompassing research, development, manufacturing, regulation, financing, distribution, and public acceptance within an integrated and forward-looking vaccine ecosystem.
The mission of ICVV is to create a shared language among academia, industry, healthcare systems, regulatory authorities, investors, and society. Through this collaboration, scientific and industrial capacities can be translated into practical solutions for disease prevention, biosecurity, public health resilience, and equitable access to vaccines.
|
Vaccine Science and Technology
Exploring advanced vaccine platforms, vaccine design, immunology, systems vaccinology, and data-driven methods for faster and more precise vaccine development.
|
Manufacturing and Industrial Development
Focusing on scalable manufacturing, quality assurance, technology transfer, biological infrastructure, and stronger connections between research and industry.
|
|
Policy and Regulation
Promoting dialogue on regulatory pathways, standardization, supportive policies, and the frameworks required for safe vaccine development and access.
|
Public Trust and Participation
Addressing health communication, public behavior, equitable access, vaccine hesitancy, and the role of social trust in successful vaccination programs.
|
| Research | Development | Clinical Trials | Manufacturing | Regulation | Access | Vaccination |
|
Scientific and Academic Community
Researchers, faculty members, physicians, veterinarians, students, and specialists in biological, medical, and public health sciences.
|
Industry and Technology
Vaccine and biological product manufacturers, knowledge-based companies, startups, biotechnology firms, and technology providers.
|
Policy and Investment
Policymakers, regulatory authorities, investors, healthcare organizations, and national and international partners.
|
• Creating opportunities for the exchange of knowledge, experience, and technology
• Developing scientific and industrial cooperation at national and international levels
• Identifying needs, capacities, and gaps across the vaccine ecosystem
• Improving preparedness and resilience against emerging diseases and health emergencies
• Expanding dialogue on equitable access, public trust, and the future of vaccination